[{"from": "human", "value": "Describe this molecule. [C][C][Branch2][Branch1][=C][C@][Branch2][Branch1][=Branch2][C][C@@H1][Branch2][Ring2][Branch1][C][=C][Branch1][Ring2][C][Ring1][=Branch1][C][=Branch2][Ring1][=Branch2][=C][C][=Branch1][Branch1][=C][Ring1][#Branch1][O][C][=Branch1][C][=O][C][=C][C][=C][C][=C][Ring1][=Branch1][C][Ring1][=N][=O][O][O][C@H1][C][C@@H1][Branch1][=Branch2][C@@H1][Branch1][Branch1][C][O][Ring1][=Branch1][O][O][N][O]"}, {"from": "gpt", "value": "The molecule is a diastereoisomeric mixture resulting from the formal reduction of the acetyl group at position 9 of amrubicin to the corresponding 1-hydroxyethyl group. The active metabolite of amrubicin in lung cancer patients. It has a role as a topoisomerase II inhibitor, an antineoplastic agent and an apoptosis inducer. It is a diastereoisomeric mixture, a member of tetracenes, a secondary alcohol and a quinone. It is functionally related to an amrubicin."}]